Sign in to continue:

us corporate news

LifeMD, Inc. 2025 Annual Report: Virtual Healthcare, Telehealth Growth, and Integrated Pharmacy Platform 101

Posted on March 11, 2026 at 11:28 pm (GMT+8)

Company Status and Regulatory Filing:

LifeMD is not a well-known seasoned issuer and is not an emerging growth company.
It has complied with all SEC filing requirements and submitted all Interactive Data Files as required.

Shareholder and Market Information:

Common Stock: Par value \$0.01 per share, trading under symbol LFMD on Nasdaq.
Preferred Stock: Series A Cumulative Perpetual Preferred Stock (8.875%, par value \$0.0001 per share), trading under symbol LFMDP on Nasdaq.
Public Float: \$512,472,017 as of June 30, 2025.
Outstanding Shares: 47,973,844 shares as of March 9, 2026.

Incorporated Documents:

Portions of the 2026 definitive proxy statement, to be filed within 120 days of year-end, are incorporated by reference. This may contain details about board changes, executive compensation, and governance that could affect share value.

View LifeMD, Inc. Historical chart here

Previous Post

Commercial Vehicle Group, Inc. 2025 Annual Report: Business Overview, Global Segments, and Financial Highlights

Next Post

Voyager Acquisition Corp. 2024 10-K: Business Strategy, Investment Criteria, and SPAC Overview